Cargando…

Targeting Bcl2 in cancer

Detalles Bibliográficos
Autores principales:	Chen, Guo, Deng, Xingming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671933/ https://www.ncbi.nlm.nih.gov/pubmed/26682258

Ejemplares similares

Bcl2 Family Functions as Signaling Target in Nicotine-/NNK-Induced Survival of Human Lung Cancer Cells
por: Deng, Xingming
Publicado: (2014)

Bcl2 inhibition of mitochondrial DNA repair
por: Xie, Maohua, et al.
Publicado: (2015)

Antagonizing Bcl-2′s BH4 domain in cancer
por: Vervloessem, Tamara, et al.
Publicado: (2015)

Targeting BCL6 and STAT3 in triple negative breast cancer: the one-two punch?
por: Walker, Sarah R., et al.
Publicado: (2015)

BCL-2 proteins: melanoma lives on the edge
por: Chipuk, Jerry Edward
Publicado: (2015)

Advances in Bcl-xL Research 2.0
por: Kervadec, Joann, et al.
Publicado: (2023)

Bcl10 mutations in malignancy
por: Dyer, M J S
Publicado: (1999)

Bcl-G acquitted of murder!
por: Tischner, D, et al.
Publicado: (2012)

Targeting BCL-2 regulated apoptosis in cancer
por: Campbell, Kirsteen J., et al.
Publicado: (2018)

BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth
por: Deng, Jiusheng, et al.
Publicado: (2016)

BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy
por: Nougarède, Adrien, et al.
Publicado: (2018)

Regulation of Apoptosis by the Bcl-2 Family of Proteins: Field on a Brink
por: Ladokhin, Alexey S.
Publicado: (2020)

TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization
por: Li, Yixiang, et al.
Publicado: (2020)

Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
por: Westhoff, Mike-Andrew, et al.
Publicado: (2022)

Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
por: Hafezi, Shirin, et al.
Publicado: (2021)

Coordinate PI3K pathway and Bcl-2 family disruption in AML
por: Bose, Prithviraj, et al.
Publicado: (2012)

Preventive Properties of Ramelteon against Cocaine-Induced Autophagia and Apoptosis: A Hypothetic Role of TNF-α Receptor Involvement and JNK/Bcl-2-Beclin1 or Bcl-2/Bax Signaling Pathway
por: Kandezi, Niyoosha, et al.
Publicado: (2020)

The epigenetic regulator CTCF modulates BCL6 in lymphoma
por: Batlle-López, Ana, et al.
Publicado: (2015)

The BCL-2 arbiters of apoptosis and their growing role as cancer targets
por: Adams, Jerry M, et al.
Publicado: (2018)

BCL-2 protein family: attractive targets for cancer therapy
por: Kaloni, Deeksha, et al.
Publicado: (2022)

ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL
por: Li, Ji-Yu, et al.
Publicado: (2012)

Tumor pyruvate kinase M2: A promising molecular target of gastrointestinal cancer
por: Guo, Chen, et al.
Publicado: (2018)

BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma
por: Esteve-Arenys, Anna, et al.
Publicado: (2018)

Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
por: de Jong, Yvonne, et al.
Publicado: (2018)

miR‐140‐3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2
por: Liu, Dingsheng, et al.
Publicado: (2021)

BCL-2 as therapeutic target for hematological malignancies
por: Perini, Guilherme Fleury, et al.
Publicado: (2018)

Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
por: Inoue-Yamauchi, Akane, et al.
Publicado: (2017)

P1280: TARGETED INHIBITION OF DHODH IS SYNERGISTIC WITH BCL2 BLOCKADE IN LYMPHOMA WITH CONCURRENT MYC AND BCL2 REARRANGEMENT
por: Mo, W., et al.
Publicado: (2022)

Targeting the BCL-2-regulated apoptotic pathway for the treatment of solid cancers
por: Fairlie, W. Douglas, et al.
Publicado: (2021)

Bcl-xL inhibition - a novel strategy for glioma therapy
por: Karpel-Massler, Georg, et al.
Publicado: (2016)

Bcl2 inhibits recruitment of Mre11 complex to DNA double-strand breaks in response to high-linear energy transfer radiation
por: Xie, Maohua, et al.
Publicado: (2015)

Immunodeficiency and CARD-BCL10-MALT1
por: Pérez de Diego, Rebeca
Publicado: (2015)

Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
por: Mena, Salvador, et al.
Publicado: (2012)

Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
por: Dupont, Thibault, et al.
Publicado: (2015)

Targeting DNA Replication Stress for Cancer Therapy
por: Zhang, Jun, et al.
Publicado: (2016)

Targeting BCL2-Proteins for the Treatment of Solid Tumours
por: Vogler, Meike
Publicado: (2014)

BCL-2 AND IAP Proteins As Potential Drug Targets
por: Fesik, Stephen W.
Publicado: (2001)

Unintended target effect of anti-BCL-2 DNAi
por: Ebrahim, Abdul Shukkur, et al.
Publicado: (2017)

Targeting the Bcl-2 Family in B Cell Lymphoma
por: Adams, Clare M., et al.
Publicado: (2019)

Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
por: Wei, Yunxiong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lp6tihu9a936o10unofunl1cs8